These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10334458)

  • 21. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
    López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
    Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon tetrachloride-induced cirrhosis in rats: influence of the acute effects of the toxin on glucose metabolism.
    Mion F; Géloën A; Agosto E; Minaire Y
    Hepatology; 1996 Mar; 23(3):582-8. PubMed ID: 8617440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of narcotic agents and of bleeding on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic rats.
    Van Roey G; Lijnen P; Verbesselt R; Verbruggen A; Fevery J
    Clin Sci (Lond); 1997 Dec; 93(6):549-56. PubMed ID: 9497792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
    Sansoè G; Aragno M; Mastrocola R; Cutrin JC; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1337-43. PubMed ID: 16449355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in glomerular filtration rate and renal plasma flow in cirrhotic rats during converting enzyme inhibition.
    Ibarra FR; Galcerán T; Oddo E; Arrizurieta E
    Ren Fail; 1998 Jan; 20(1):65-74. PubMed ID: 9509561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of spleen on inducing portal hypertension and liver cirrhosis in rats].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):338-40, 381-2. PubMed ID: 1332811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
    J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver cirrhosis induced by carbon tetrachloride and the effect of superoxide dismutase and xanthine oxidase inhibitor treatment.
    Dashti HM; al-Sayer H; Behbehani A; Madda J; Christenson JT
    J R Coll Surg Edinb; 1992 Feb; 37(1):23-8. PubMed ID: 1573602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological sequence of hepatic and renal lesions in rats after cessation of the repeated administration of CCl4.
    Ogata S; Takeda M; Lee MJ; Itagaki S; Doi K
    Exp Toxicol Pathol; 1995 Dec; 47(6):493-9. PubMed ID: 8871089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat.
    Harry D; Anand R; Holt S; Davies S; Marley R; Fernando B; Goodier D; Moore K
    Hepatology; 1999 Nov; 30(5):1198-205. PubMed ID: 10534341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic octreotide treatment on renal changes during cirrhosis in rats.
    Jonassen TE; Christensen S; Sørensen AM; Marcussen N; Flyvbjerg A; Andreasen F; Petersen JS
    Hepatology; 1999 May; 29(5):1387-95. PubMed ID: 10216120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrarenal octreotide treatment prevents sodium retention in liver cirrhotic rats: evidence for direct effects within the thick ascending limb of Henle's loop.
    Jonassen TE; Christensen S; Marcussen N; Petersen JS
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F537-45. PubMed ID: 16418303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of volatile anesthetics or fentanyl on hepatic function in cirrhotic rats.
    Baden JM; Kundomal YR; Luttropp ME; Maze M; Kosek JC
    Anesth Analg; 1985 Dec; 64(12):1183-8. PubMed ID: 4061900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.
    Fernández-Varo G; Melgar-Lesmes P; Casals G; Pauta M; Arroyo V; Morales-Ruiz M; Ros J; Jiménez W
    J Hepatol; 2010 Dec; 53(6):1041-8. PubMed ID: 20800923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.
    Bosch-Marcé M; Morales-Ruiz M; Jiménez W; Bordas N; Solé M; Ros J; Deulofeu R; Arroyo V; Rivera F; Rodés J
    Hepatology; 1998 May; 27(5):1191-9. PubMed ID: 9581670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of zinc on hepatic ornithine transcarbamylase (OTC) activity.
    Aquilio E; Spagnoli R; Riggio D; Seri S
    J Trace Elem Electrolytes Health Dis; 1993 Dec; 7(4):240-1. PubMed ID: 8019156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal and systemic hemodynamics in experimental cirrhosis in rats: relation to hepatic function.
    Wensing G; Sabra R; Branch RA
    Hepatology; 1990 Jul; 12(1):13-9. PubMed ID: 2197209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model of acute kidney injury in mice with cirrhosis and infection.
    Carl DE; Ghosh SS; Gehr TW; Abbate A; Toldo S; Sanyal AJ
    Liver Int; 2016 Jun; 36(6):865-73. PubMed ID: 26583566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.